#United States #Class Action #Pittsburgh #securities litigation #Mylan

Proposed Settlement in Mylan N.V. Securities Litigation

In a significant development for investors, Bernstein Litowitz Berger & Grossmann LLP and Kessler Topaz Meltzer & Check, LLP have jointly announced the pendency of a class action lawsuit alongside a proposed settlement concerning Mylan N.V. The class action, which is currently being processed in the United States District Court for the Western District of Pennsylvania, primarily affects individuals and entities that purchased Mylan's publicly traded common stock during the period from February 16, 2016 to May 7, 2019.

Background on the Case

The lawsuit alleges that Mylan, along with certain senior executives, including Chief Executive Officer Heather Bresch, President Rajiv Malik, and Chief Financial Officer Kenneth Parks, breached federal securities laws. Specifically, the complaint details accusations of material misrepresentations and omissions regarding regulatory compliance and FDA inspections at Mylan's facilities. These allegations are said to violate Section 10(b) of the Securities Exchange Act of 1934, while it is also asserted that the defendants had control over Mylan during the period in question, thereby violating Section 20(a).

Mylan, through its legal team, fervently denies any wrongdoing, asserting that the claims brought forth by the Lead Plaintiff, the Public Employees' Retirement System of Mississippi, are unfounded.

Settlement Proposal

The proposed settlement, if approved, amounts to $60 million in cash aimed at compensating affected investors within the settlement class. A key aspect of this resolution will be discussed during a hearing scheduled for June 15, 2026, where the court will evaluate several facets:

• - The fairness, reasonableness, and adequacy of the proposed settlement.
• - Whether the action should be certified as a class action for the settlement class, and the appointment of lead counsel.
• - Potential dismissal of the action against the defendants and the implications of the proposed plan of allocation for distributing settlement funds.

Important Dates to Highlight

Investors interested in participating in this settlement must be vigilant about the following deadlines:

• - Claim Submission: Members of the settlement class need to submit a Claim Form by July 10, 2026. Failure to do so might disqualify them from receiving any compensation, though they will still be subject to the court’s decisions.
• - Exclusion Requests: Those who wish to opt out of the settlement class must submit a request for exclusion by May 15, 2026. Excluding oneself means waiving the right to seek compensation but also releases them from any court rulings regarding the lawsuit.
• - Objections: Any objections to the settlement or related plans need to be submitted to the court by May 15, 2026.

How to Stay Informed

For further details about the settlement, class members can visit the dedicated website www.Mylan2026SecuritiesSettlement.com or contact the Claims Administrator through various avenues listed in the settlement notice. They can obtain comprehensive information, including the full notice and claim forms.

As the hearing date approaches, stakeholders are encouraged to remain updated on any adjustments regarding the hearing's time or format, which may shift to accommodate virtual attendance.

Conclusion

The Mylan securities litigation case is pivotal for investors impacted by the alleged misstatements about the company's compliance and regulatory status. With a proposed settlement already on the table and significant upcoming deadlines, it is crucial for those affected to engage actively in the process to safeguard their rights and potential settlements. Legal counsel may provide additional guidance throughout this complex scenario, ensuring that all participants take informed actions towards resolution.